Asia has become "much, much smarter" in the way they handle further coronavirus outbreaks, which will help the region's aviation industry recover in a "much more sustainable" way, said AirAsia CEO Tony Fernandes.
The results showed that out of 2,045 blood samples collected from students and teachers from across 13 secondary schools in the region only 12 samples were found to contain antibodies against Covid-19.
The charts, as interpreted by the legendary Larry Williams, suggest the S&P 500 could climb another 5% in coming weeks before equities begin to retreat, the "Mad Money" host said.
"Something happened in mid-June that we're now confronting right now," Redfield said. "And it's not as simple as just saying it was related to timing of reopening or not reopening."
Parking lots, of all places, are turning into bigger sources of revenue for some mall owners during the coronavirus pandemic. They're hosting drive-in movie theaters, food venues and more.
The Trump administration has increasingly disregarded advice from its top scientific advisors on Covid-19, with Trump himself calling the CDC's guidelines on school reopenings too cumbersome and expensive.
As Tulane University prepares to bring students back to campus in the fall amid the coronavirus pandemic, Dean of Students Erica Woodley has a message: party or be in large gatherings, and you're in trouble.
Amid one of the worst public health crises in history, a record number of laid-off Americans have lost their health insruance. Here's what you can do to get covered.
Wedged into a strip mall in Nashville's Green Hills neighborhood, between a barber shop and a hair salon, is not where you'd expect to find an iconic music venue. Yet there it sits, The Bluebird Café, founded in 1982. The small "listening room" has been a stepping stone for many of the top artists and songwriters in country music.
Moderna will begin its late-stage trial testing a potential vaccine to prevent Covid-19 on July 27, according to a posting published Tuesday on ClinicalTrials.gov.
As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has never tested a product in humans or made any revenue.